查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1801305

全球分子诊断市场：产业分析、规模、份额、成长、趋势与预测（2025-2032）

Molecular Diagnostics Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2025 - 2032
出版日期: | 出版商: Persistence Market Research | 英文 225 Pages | 商品交期: 2-5个工作天内

价格
简介目录

预计 2025 年全球分子诊断市场价值将达到 252 亿美元，到 2032 年将达到 434 亿美元，预测期内（2025-2032 年）的复合年增长率为 8.1%。

分子诊断透过分析基因组和蛋白质组中的生物标记来诊断和监测疾病、检测风险并确定每位患者最合适的治疗方法。由于其准确性、速度和个人化治疗的潜力，该领域在临床实践中变得越来越重要。分子诊断市场涵盖PCR、NGS、微阵列和原位杂合反应等技术，广泛应用于医院、诊断实验室、研究机构和居家医疗机构。市场扩张的驱动力包括：对早期疾病检测日益增长的需求、感染疾病和慢性病的日益普及以及分子技术的持续创新。

市场驱动因素

全球分子诊断市场受多种关键因素驱动，包括新冠肺炎 (COVID-19)、爱滋病毒 (HIV)、肝炎和结核病等感染疾病负担的不断加重。此外，对个人化医疗和标靶治疗的日益重视也推动了对精准分子检测的需求。照护现场)的日益普及，以及伴随诊断在肿瘤学中的广泛应用，进一步推动了需求成长。自动化、即时PCR和次世代定序技术的进步，正在提高诊断效率、速度和灵敏度，扩大其在整个医疗保健系统中的市场应用。

市场限制

儘管成长前景光明，分子诊断市场仍面临设备和检测成本高等挑战，尤其是在中低收入国家。报销限制（尤其是新型诊断工具的报销限制）限制了其可近性。复杂的监管和冗长的核准流程也对创新和市场准入构成了障碍。此外，在资源有限的环境中，熟练实验室专业人员的短缺和基础设施的限制也阻碍了先进分子诊断技术的推广。

市场机会

由于分子诊断在肿瘤学、基因检测、药物基因组学和感染疾病管理等领域的应用不断扩展，该市场蕴含着巨大的成长机会。人工智慧与生物资讯学在数据分析领域的融合正在改变诊断领域。科学研究投入的增加以及公私合营的加强，正在推动尖端分子侦测的创新和商业化。人们对早期疾病检测意识的提升以及医疗保健支出的不断增长（尤其是在新兴市场），预计将为市场扩张开闢新的途径。此外，可携式、易于使用的就地检验分子诊断套件的开发，有望彻底改变都市区和偏远地区的患者照护。

本报告研究了全球分子诊断市场，按产品类型、疾病领域、最终用途和地理趋势进行细分，并介绍了参与市场的公司概况。

目录

第一章执行摘要

第二章 市场概述

  • 市场范围和定义
  • 价值链分析
  • 宏观经济因素
  • 预测因子－相关性和影响力
  • COVID-19影响评估
  • PESTLE分析
  • 波特五力分析
  • 地缘政治紧张局势：市场影响
  • 监管和技术格局

第三章 市场动态

  • 驱动程式
  • 抑制因素
  • 机会
  • 趋势

第四章 2019-2032年价格趋势分析

  • 区域价格分析
  • 按细分市场定价
  • 价格影响因素

第五章全球分子诊断市场展望：实际情况（2019-2024 年）与预测（2025-2032 年）

  • 主要亮点
  • 全球分子诊断市场按产品类型展望
    • 简介/主要发现
    • 2019-2024 年产品类型市场规模趋势分析
    • 2025 年至 2032 年按产品类型分類的当前市场规模预测
      • 装置
        • 聚合酵素链锁反应（PCR）系统
        • 杂合反应（原位杂合反应和FISH）系统
        • DNA定序与次世代定序平台
        • 微阵列
      • 试剂
        • 抗体
        • DNA模板
        • DNA聚合酵素
        • 寡核苷酸引子
        • 脱氧核糖核苷酸三磷酸（dNTP）
        • 缓衝
      • 检测试剂套件
      • 耗材
    • 按产品类型进行的市场吸引力分析
  • 全球分子诊断市场按治疗领域展望
    • 简介/主要发现
    • 2019-2024年按疾病领域分類的市场规模趋势分析
    • 2025 年至 2032 年按治疗领域分類的当前市场规模预测
      • 感染疾病
      • 糖尿病
      • 心臟病学
      • 肿瘤学
      • 肾臟病学
      • 自体免疫疾病
      • 皮肤科
      • 创伤护理
      • 其他的
    • 依治疗领域分析市场吸引力
  • 全球分子诊断市场展望（按最终用途）
    • 简介/主要发现
    • 2019-2024 年按最终用途分類的市场规模分析
    • 2025 年至 2032 年按最终用途分類的当前市场规模预测
      • 医院和诊所
      • 诊断实验室
      • 学术研究机构
      • 生物製药公司
    • 依最终用途进行市场吸引力分析

6. 全球分子诊断市场（按地区）展望

  • 主要亮点
  • 2019-2024 年各地区市场规模趋势分析
  • 2025 年至 2032 年各地区目前市场规模预测
    • 北美洲
    • 欧洲
    • 东亚
    • 南亚和大洋洲
    • 拉丁美洲
    • 中东和非洲
  • 按地区分析市场吸引力

第七章北美分子诊断市场展望：实际（2019-2024）与预测（2025-2032）

8. 欧洲分子诊断市场展望：实际情况（2019-2024 年）与预测（2025-2032 年）

第九章东亚分子诊断市场展望：实际（2019-2024）与预测（2025-2032）

第 10 章南亚和大洋洲分子诊断市场展望：实际（2019-2024 年）和预测（2025-2032 年）

第 11 章拉丁美洲分子诊断市场展望：实际（2019-2024 年）和预测（2025-2032 年）

第 12 章。中东和非洲分子诊断市场展望：实际（2019-2024 年）和预测（2025-2032 年）

第十三章竞争格局

  • 2025年市场占有率分析
  • 市场结构
  • 公司简介
    • Becton, Dickinson and Company
    • Bio-Rad Laboratories In
    • Merck KgaA
    • Thermo Fisher Scientific Inc
    • Agilent Technologies, Inc.
    • F. Hoffman-La Roche Ltd.
    • Illumina, Inc.
    • Qiagen NV
    • Hologic Inc.
    • Siemens Healthineers AG
    • Seegene, Inc.
    • DiaSorin SpA
    • Grifols, SA
    • bioMerieux
    • QuidelOrtho Corporation

第十四章 附录

简介目录
Product Code: PMRREP2784

Persistence Market Research has recently released a comprehensive report on the worldwide market for molecular diagnostics. The report offers a thorough assessment of crucial market dynamics, including drivers, trends, opportunities, and challenges, providing detailed insights into the market structure.

Key Insights:

  • Molecular Diagnostics Market Size (2025E): USD 25.2 Billion
  • Projected Market Value (2032F): USD 43.4 Billion
  • Global Market Growth Rate (CAGR 2025 to 2032): 8.1%

Molecular Diagnostics Market - Report Scope:

Molecular diagnostics involves the analysis of biological markers in the genome and proteome to diagnose and monitor disease, detect risk, and decide which therapies will work best for individual patients. This segment has become increasingly essential in clinical practice due to its accuracy, speed, and potential for personalization of treatment. The molecular diagnostics market serves hospitals, diagnostic laboratories, research institutes, and homecare settings, encompassing technologies like PCR, NGS, microarrays, and in situ hybridization. Market expansion is being driven by rising demand for early disease detection, increased prevalence of infectious and chronic diseases, and continuous innovations in molecular technologies.

Market Growth Drivers:

The global molecular diagnostics market is propelled by several key factors, including the rising burden of infectious diseases such as COVID-19, HIV, hepatitis, and tuberculosis. Additionally, the growing emphasis on personalized medicine and targeted therapies necessitates accurate molecular testing. The increasing use of point-of-care diagnostics, along with the proliferation of companion diagnostics in oncology, further enhances the demand. Technological advancements in automation, real-time PCR, and next-generation sequencing are improving diagnostic efficiency, speed, and sensitivity, thereby expanding market adoption across healthcare systems.

Market Restraints:

Despite promising growth, the molecular diagnostics market faces certain challenges, such as high cost of instruments and tests, especially in low- and middle-income countries. Reimbursement limitations, particularly for novel diagnostic tools, restrict accessibility. Regulatory complexities and time-consuming approval processes also act as barriers to innovation and market entry. Furthermore, the shortage of skilled laboratory professionals and infrastructure constraints in resource-limited settings hinder the adoption of advanced molecular diagnostics.

Market Opportunities:

The molecular diagnostics market presents significant growth opportunities fueled by expanding applications in oncology, genetic testing, pharmacogenomics, and infectious disease management. The integration of artificial intelligence and bioinformatics for data analysis is transforming the diagnostic landscape. Increasing investments in research and public-private collaborations are promoting innovation and commercialization of cutting-edge molecular tests. Growing awareness about early disease detection and rising healthcare spending, especially in emerging markets, are expected to unlock new avenues for market expansion. Additionally, the development of portable and easy-to-use molecular diagnostic kits for point-of-care testing is set to revolutionize patient care in both urban and remote areas.

Key Questions Answered in the Report:

  • What are the primary factors driving the growth of the molecular diagnostics market globally?
  • Which technologies and applications are most widely adopted in clinical molecular diagnostics?
  • How are emerging technologies like NGS and AI impacting the competitive landscape?
  • Who are the leading companies in the molecular diagnostics market, and what strategies are they using to stay competitive?
  • What are the key trends and future outlook for the global molecular diagnostics market?

Competitive Intelligence and Business Strategy:

These companies focus on expanding their test portfolios, developing multiplex and syndromic testing panels, and enhancing automation and throughput of diagnostic systems. Collaborations with biotechnology firms, diagnostic labs, and healthcare institutions drive access and adoption. Furthermore, companies are prioritizing regulatory approvals, market expansion in developing economies, and customer-centric strategies to reinforce their global presence.

Key Companies Profiled:

  • Becton, Dickinson and Company
  • Bio-Rad Laboratories In
  • Merck KgaA
  • Thermo Fisher Scientific Inc
  • Agilent Technologies, Inc.
  • F. Hoffman - La Roche Ltd.
  • Illumina, Inc.
  • Qiagen N.V.
  • Hologic Inc.
  • Siemens Healthineers AG
  • Seegene, Inc.
  • DiaSorin S.p.A
  • Grifols, S.A.
  • bioMerieux
  • QuidelOrtho Corporation
  • RapidBio
  • Abbott Laboratories
  • Danaher Corporation

Molecular Diagnostics Market Research Segmentation:

By Product Type:

  • Instruments
    • * Polymerase Chain Reaction (PCR) Systems
    • * Hybridization (In-Situ Hybridization & Fish) Systems
    • * DNA Sequencing and Next-Generation Sequencing Platforms
    • * Microarrays
  • Reagent
    • * Antibodies
    • * DNA Template
    • * DNA Polymerase
    • * Oligonucleotide Primers
    • * Deoxyribonucleotide Triphosphate (dNTPs)
    • * Buffer
  • Assay Kits
  • Consumables

By Disease Area:

  • Infectious Disease
  • Diabetes
  • Cardiology
  • Oncology
  • Nephrology
  • Autoimmune Disease
  • Dermatology
  • Wound Care
  • Others

By End-use:

  • Hospitals & Clinics
  • Diagnostics Laboratories
  • Academic and Research Institutes
  • Biopharmaceutical Companies

By Region:

  • North America
  • Europe
  • East Asia
  • South Asia & Oceania
  • Latin America
  • Middle East & Africa

Table of Contents

1. Executive Summary

  • 1.1. Global Molecular Diagnostics Market Snapshot 2025 and 2032
  • 1.2. Market Opportunity Assessment, 2025-2032, US$ Bn
  • 1.3. Key Market Trends
  • 1.4. Industry Developments and Key Market Events
  • 1.5. Demand Side and Supply Side Analysis
  • 1.6. PMR Analysis and Recommendations

2. Market Overview

  • 2.1. Market Scope and Definitions
  • 2.2. Value Chain Analysis
  • 2.3. Macro-Economic Factors
    • 2.3.1. Global GDP Outlook
    • 2.3.2. Global GDP Outlook
    • 2.3.3. Global economic Growth Forecast
    • 2.3.4. Global Urbanization Growth
    • 2.3.5. Other Macro-economic Factors
  • 2.4. Forecast Factors - Relevance and Impact
  • 2.5. COVID-19 Impact Assessment
  • 2.6. PESTLE Analysis
  • 2.7. Porter's Five Forces Analysis
  • 2.8. Geopolitical Tensions: Market Impact
  • 2.9. Regulatory and Technology Landscape

3. Market Dynamics

  • 3.1. Drivers
  • 3.2. Restraints
  • 3.3. Opportunities
  • 3.4. Trends

4. Price Trend Analysis, 2019-2032

  • 4.1. Region-wise Price Analysis
  • 4.2. Price by Segments
  • 4.3. Price Impact Factors

5. Global Molecular Diagnostics Market Outlook: Historical (2019-2024) and Forecast (2025-2032)

  • 5.1. Key Highlights
  • 5.2. Global Molecular Diagnostics Market Outlook: Product Type
    • 5.2.1. Introduction/Key Findings
    • 5.2.2. Historical Market Size (US$ Bn) Analysis by Product Type, 2019-2024
    • 5.2.3. Current Market Size (US$ Bn) Forecast, by Product Type, 2025-2032
      • 5.2.3.1. Instruments
        • 5.2.3.1.1. Polymerase Chain Reaction (PCR) Systems
        • 5.2.3.1.2. Hybridization (In-Situ Hybridization & Fish) Systems
        • 5.2.3.1.3. DNA Sequencing and Next-Generation Sequencing Platforms
        • 5.2.3.1.4. Microarrays
      • 5.2.3.2. Reagent
        • 5.2.3.2.1. Antibodies
        • 5.2.3.2.2. DNA Template
        • 5.2.3.2.3. DNA Polymerase
        • 5.2.3.2.4. Oligonucleotide Primers
        • 5.2.3.2.5. Deoxyribonucleotide Triphosphate (dNTPs)
        • 5.2.3.2.6. Buffer
      • 5.2.3.3. Assay Kits
      • 5.2.3.4. Consumables
    • 5.2.4. Market Attractiveness Analysis: Product Type
  • 5.3. Global Molecular Diagnostics Market Outlook: Disease Area
    • 5.3.1. Introduction/Key Findings
    • 5.3.2. Historical Market Size (US$ Bn) Analysis by Disease Area, 2019-2024
    • 5.3.3. Current Market Size (US$ Bn) Forecast, by Disease Area, 2025-2032
      • 5.3.3.1. Infectious Disease
      • 5.3.3.2. Diabetes
      • 5.3.3.3. Cardiology
      • 5.3.3.4. Oncology
      • 5.3.3.5. Nephrology
      • 5.3.3.6. Autoimmune Disease
      • 5.3.3.7. Dermatology
      • 5.3.3.8. Wound Care
      • 5.3.3.9. Others
    • 5.3.4. Market Attractiveness Analysis: Disease Area
  • 5.4. Global Molecular Diagnostics Market Outlook: End-use
    • 5.4.1. Introduction/Key Findings
    • 5.4.2. Historical Market Size (US$ Bn) Analysis by End-use, 2019-2024
    • 5.4.3. Current Market Size (US$ Bn) Forecast, by End-use, 2025-2032
      • 5.4.3.1. Hospitals & Clinics
      • 5.4.3.2. Diagnostics Laboratories
      • 5.4.3.3. Academic and Research Institutes
      • 5.4.3.4. Biopharmaceutical Companies
    • 5.4.4. Market Attractiveness Analysis: End-use

6. Global Molecular Diagnostics Market Outlook: Region

  • 6.1. Key Highlights
  • 6.2. Historical Market Size (US$ Bn) Analysis by Region, 2019-2024
  • 6.3. Current Market Size (US$ Bn) Forecast, by Region, 2025-2032
    • 6.3.1. North America
    • 6.3.2. Europe
    • 6.3.3. East Asia
    • 6.3.4. South Asia & Oceania
    • 6.3.5. Latin America
    • 6.3.6. Middle East & Africa
  • 6.4. Market Attractiveness Analysis: Region

7. North America Molecular Diagnostics Market Outlook: Historical (2019-2024) and Forecast (2025-2032)

  • 7.1. Key Highlights
  • 7.2. Pricing Analysis
  • 7.3. North America Market Size (US$ Bn) Forecast, by Country, 2025-2032
    • 7.3.1. U.S.
    • 7.3.2. Canada
  • 7.4. North America Market Size (US$ Bn) Forecast, by Product Type, 2025-2032
    • 7.4.1. Instruments
      • 7.4.1.1. Polymerase Chain Reaction (PCR) Systems
      • 7.4.1.2. Hybridization (In-Situ Hybridization & Fish) Systems
      • 7.4.1.3. DNA Sequencing and Next-Generation Sequencing Platforms
      • 7.4.1.4. Microarrays
    • 7.4.2. Reagent
      • 7.4.2.1. Antibodies
      • 7.4.2.2. DNA Template
      • 7.4.2.3. DNA Polymerase
      • 7.4.2.4. Oligonucleotide Primers
      • 7.4.2.5. Deoxyribonucleotide Triphosphate (dNTPs)
      • 7.4.2.6. Buffer
    • 7.4.3. Assay Kits
    • 7.4.4. Consumables
  • 7.5. North America Market Size (US$ Bn) Forecast, by Disease Area, 2025-2032
    • 7.5.1. Infectious Disease
    • 7.5.2. Diabetes
    • 7.5.3. Cardiology
    • 7.5.4. Oncology
    • 7.5.5. Nephrology
    • 7.5.6. Autoimmune Disease
    • 7.5.7. Dermatology
    • 7.5.8. Wound Care
    • 7.5.9. Others
  • 7.6. North America Market Size (US$ Bn) Forecast, by End-use, 2025-2032
    • 7.6.1. Hospitals & Clinics
    • 7.6.2. Diagnostics Laboratories
    • 7.6.3. Academic and Research Institutes
    • 7.6.4. Biopharmaceutical Companies

8. Europe Molecular Diagnostics Market Outlook: Historical (2019-2024) and Forecast (2025-2032)

  • 8.1. Key Highlights
  • 8.2. Pricing Analysis
  • 8.3. Europe Market Size (US$ Bn) Forecast, by Country, 2025-2032
    • 8.3.1. Germany
    • 8.3.2. Italy
    • 8.3.3. France
    • 8.3.4. U.K.
    • 8.3.5. Spain
    • 8.3.6. Russia
    • 8.3.7. Rest of Europe
  • 8.4. Europe Market Size (US$ Bn) Forecast, by Product Type, 2025-2032
    • 8.4.1. Instruments
      • 8.4.1.1. Polymerase Chain Reaction (PCR) Systems
      • 8.4.1.2. Hybridization (In-Situ Hybridization & Fish) Systems
      • 8.4.1.3. DNA Sequencing and Next-Generation Sequencing Platforms
      • 8.4.1.4. Microarrays
    • 8.4.2. Reagent
      • 8.4.2.1. Antibodies
      • 8.4.2.2. DNA Template
      • 8.4.2.3. DNA Polymerase
      • 8.4.2.4. Oligonucleotide Primers
      • 8.4.2.5. Deoxyribonucleotide Triphosphate (dNTPs)
      • 8.4.2.6. Buffer
    • 8.4.3. Assay Kits
    • 8.4.4. Consumables
  • 8.5. Europe Market Size (US$ Bn) Forecast, by Disease Area, 2025-2032
    • 8.5.1. Infectious Disease
    • 8.5.2. Diabetes
    • 8.5.3. Cardiology
    • 8.5.4. Oncology
    • 8.5.5. Nephrology
    • 8.5.6. Autoimmune Disease
    • 8.5.7. Dermatology
    • 8.5.8. Wound Care
    • 8.5.9. Others
  • 8.6. Europe Market Size (US$ Bn) Forecast, by End-use, 2025-2032
    • 8.6.1. Hospitals & Clinics
    • 8.6.2. Diagnostics Laboratories
    • 8.6.3. Academic and Research Institutes
    • 8.6.4. Biopharmaceutical Companies

9. East Asia Molecular Diagnostics Market Outlook: Historical (2019-2024) and Forecast (2025-2032)

  • 9.1. Key Highlights
  • 9.2. Pricing Analysis
  • 9.3. East Asia Market Size (US$ Bn) Forecast, by Country, 2025-2032
    • 9.3.1. China
    • 9.3.2. Japan
    • 9.3.3. South Korea
  • 9.4. East Asia Market Size (US$ Bn) Forecast, by Product Type, 2025-2032
    • 9.4.1. Instruments
      • 9.4.1.1. Polymerase Chain Reaction (PCR) Systems
      • 9.4.1.2. Hybridization (In-Situ Hybridization & Fish) Systems
      • 9.4.1.3. DNA Sequencing and Next-Generation Sequencing Platforms
      • 9.4.1.4. Microarrays
    • 9.4.2. Reagent
      • 9.4.2.1. Antibodies
      • 9.4.2.2. DNA Template
      • 9.4.2.3. DNA Polymerase
      • 9.4.2.4. Oligonucleotide Primers
      • 9.4.2.5. Deoxyribonucleotide Triphosphate (dNTPs)
      • 9.4.2.6. Buffer
    • 9.4.3. Assay Kits
    • 9.4.4. Consumables
  • 9.5. East Asia Market Size (US$ Bn) Forecast, by Disease Area, 2025-2032
    • 9.5.1. Infectious Disease
    • 9.5.2. Diabetes
    • 9.5.3. Cardiology
    • 9.5.4. Oncology
    • 9.5.5. Nephrology
    • 9.5.6. Autoimmune Disease
    • 9.5.7. Dermatology
    • 9.5.8. Wound Care
    • 9.5.9. Others
  • 9.6. East Asia Market Size (US$ Bn) Forecast, by End-use, 2025-2032
    • 9.6.1. Hospitals & Clinics
    • 9.6.2. Diagnostics Laboratories
    • 9.6.3. Academic and Research Institutes
    • 9.6.4. Biopharmaceutical Companies

10. South Asia & Oceania Molecular Diagnostics Market Outlook: Historical (2019-2024) and Forecast (2025-2032)

  • 10.1. Key Highlights
  • 10.2. Pricing Analysis
  • 10.3. South Asia & Oceania Market Size (US$ Bn) Forecast, by Country, 2025-2032
    • 10.3.1. India
    • 10.3.2. Southeast Asia
    • 10.3.3. ANZ
    • 10.3.4. Rest of SAO
  • 10.4. South Asia & Oceania Market Size (US$ Bn) Forecast, by Product Type, 2025-2032
    • 10.4.1. Instruments
      • 10.4.1.1. Polymerase Chain Reaction (PCR) Systems
      • 10.4.1.2. Hybridization (In-Situ Hybridization & Fish) Systems
      • 10.4.1.3. DNA Sequencing and Next-Generation Sequencing Platforms
      • 10.4.1.4. Microarrays
    • 10.4.2. Reagent
      • 10.4.2.1. Antibodies
      • 10.4.2.2. DNA Template
      • 10.4.2.3. DNA Polymerase
      • 10.4.2.4. Oligonucleotide Primers
      • 10.4.2.5. Deoxyribonucleotide Triphosphate (dNTPs)
      • 10.4.2.6. Buffer
    • 10.4.3. Assay Kits
    • 10.4.4. Consumables
  • 10.5. South Asia & Oceania Market Size (US$ Bn) Forecast, by Disease Area, 2025-2032
    • 10.5.1. Infectious Disease
    • 10.5.2. Diabetes
    • 10.5.3. Cardiology
    • 10.5.4. Oncology
    • 10.5.5. Nephrology
    • 10.5.6. Autoimmune Disease
    • 10.5.7. Dermatology
    • 10.5.8. Wound Care
    • 10.5.9. Others
  • 10.6. South Asia & Oceania Market Size (US$ Bn) Forecast, by End-use, 2025-2032
    • 10.6.1. Hospitals & Clinics
    • 10.6.2. Diagnostics Laboratories
    • 10.6.3. Academic and Research Institutes
    • 10.6.4. Biopharmaceutical Companies

11. Latin America Molecular Diagnostics Market Outlook: Historical (2019-2024) and Forecast (2025-2032)

  • 11.1. Key Highlights
  • 11.2. Pricing Analysis
  • 11.3. Latin America Market Size (US$ Bn) Forecast, by Country, 2025-2032
    • 11.3.1. Brazil
    • 11.3.2. Mexico
    • 11.3.3. Rest of LATAM
  • 11.4. Latin America Market Size (US$ Bn) Forecast, by Product Type, 2025-2032
    • 11.4.1. Instruments
      • 11.4.1.1. Polymerase Chain Reaction (PCR) Systems
      • 11.4.1.2. Hybridization (In-Situ Hybridization & Fish) Systems
      • 11.4.1.3. DNA Sequencing and Next-Generation Sequencing Platforms
      • 11.4.1.4. Microarrays
    • 11.4.2. Reagent
      • 11.4.2.1. Antibodies
      • 11.4.2.2. DNA Template
      • 11.4.2.3. DNA Polymerase
      • 11.4.2.4. Oligonucleotide Primers
      • 11.4.2.5. Deoxyribonucleotide Triphosphate (dNTPs)
      • 11.4.2.6. Buffer
    • 11.4.3. Assay Kits
    • 11.4.4. Consumables
  • 11.5. Latin America Market Size (US$ Bn) Forecast, by Disease Area, 2025-2032
    • 11.5.1. Infectious Disease
    • 11.5.2. Diabetes
    • 11.5.3. Cardiology
    • 11.5.4. Oncology
    • 11.5.5. Nephrology
    • 11.5.6. Autoimmune Disease
    • 11.5.7. Dermatology
    • 11.5.8. Wound Care
    • 11.5.9. Others
  • 11.6. Latin America Market Size (US$ Bn) Forecast, by End-use, 2025-2032
    • 11.6.1. Hospitals & Clinics
    • 11.6.2. Diagnostics Laboratories
    • 11.6.3. Academic and Research Institutes
    • 11.6.4. Biopharmaceutical Companies

12. Middle East & Africa Molecular Diagnostics Market Outlook: Historical (2019-2024) and Forecast (2025-2032)

  • 12.1. Key Highlights
  • 12.2. Pricing Analysis
  • 12.3. Middle East & Africa Market Size (US$ Bn) Forecast, by Country, 2025-2032
    • 12.3.1. GCC Countries
    • 12.3.2. South Africa
    • 12.3.3. Northern Africa
    • 12.3.4. Rest of MEA
  • 12.4. Middle East & Africa Market Size (US$ Bn) Forecast, by Product Type, 2025-2032
    • 12.4.1. Instruments
      • 12.4.1.1. Polymerase Chain Reaction (PCR) Systems
      • 12.4.1.2. Hybridization (In-Situ Hybridization & Fish) Systems
      • 12.4.1.3. DNA Sequencing and Next-Generation Sequencing Platforms
      • 12.4.1.4. Microarrays
    • 12.4.2. Reagent
      • 12.4.2.1. Antibodies
      • 12.4.2.2. DNA Template
      • 12.4.2.3. DNA Polymerase
      • 12.4.2.4. Oligonucleotide Primers
      • 12.4.2.5. Deoxyribonucleotide Triphosphate (dNTPs)
      • 12.4.2.6. Buffer
    • 12.4.3. Assay Kits
    • 12.4.4. Consumables
  • 12.5. Middle East & Africa Market Size (US$ Bn) Forecast, by Disease Area, 2025-2032
    • 12.5.1. Infectious Disease
    • 12.5.2. Diabetes
    • 12.5.3. Cardiology
    • 12.5.4. Oncology
    • 12.5.5. Nephrology
    • 12.5.6. Autoimmune Disease
    • 12.5.7. Dermatology
    • 12.5.8. Wound Care
    • 12.5.9. Others
  • 12.6. Middle East & Africa Market Size (US$ Bn) Forecast, by End-use, 2025-2032
    • 12.6.1. Hospitals & Clinics
    • 12.6.2. Diagnostics Laboratories
    • 12.6.3. Academic and Research Institutes
    • 12.6.4. Biopharmaceutical Companies

13. Competition Landscape

  • 13.1. Market Share Analysis, 2025
  • 13.2. Market Structure
    • 13.2.1. Competition Intensity Mapping
    • 13.2.2. Competition Dashboard
  • 13.3. Company Profiles
    • 13.3.1. Becton, Dickinson and Company
      • 13.3.1.1. Company Overview
      • 13.3.1.2. Product Portfolio/Offerings
      • 13.3.1.3. Key Financials
      • 13.3.1.4. SWOT Analysis
      • 13.3.1.5. Company Strategy and Key Developments
    • 13.3.2. Bio-Rad Laboratories In
    • 13.3.3. Merck KgaA
    • 13.3.4. Thermo Fisher Scientific Inc
    • 13.3.5. Agilent Technologies, Inc.
    • 13.3.6. F. Hoffman - La Roche Ltd.
    • 13.3.7. Illumina, Inc.
    • 13.3.8. Qiagen N.V.
    • 13.3.9. Hologic Inc.
    • 13.3.10. Siemens Healthineers AG
    • 13.3.11. Seegene, Inc.
    • 13.3.12. DiaSorin S.p.A
    • 13.3.13. Grifols, S.A.
    • 13.3.14. bioMerieux
    • 13.3.15. QuidelOrtho Corporation

14. Appendix

  • 14.1. Research Methodology
  • 14.2. Research Assumptions
  • 14.3. Acronyms and Abbreviations